1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with lovastatin in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (lovastatin) | Trials (lovastatin) | Recent Studies (post-2010) (lovastatin) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 4,828 | 698 | 873 |
Protein | Taxonomy | 1-hexadecyl-2-acetyl-glycero-3-phosphocholine (IC50) | lovastatin (IC50) |
---|---|---|---|
Chain A, Antigen Cd11a (p180) | Homo sapiens (human) | 2.4 | |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Homo sapiens (human) | 0.0261 | |
Integrin beta-2 | Homo sapiens (human) | 3.09 | |
Intercellular adhesion molecule 1 | Homo sapiens (human) | 3.78 | |
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 8.753 | |
ATP-dependent translocase ABCB1 | Homo sapiens (human) | 10 | |
Neutrophil elastase | Homo sapiens (human) | 0.027 | |
Insulin receptor | Rattus norvegicus (Norway rat) | 0.02 | |
Integrin alpha-L | Homo sapiens (human) | 3.09 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 8.753 | |
Prostaglandin G/H synthase 2 | Homo sapiens (human) | 0.02 | |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | Rattus norvegicus (Norway rat) | 0.0529 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hong, J; Im, KS; Jung, JH; Kim, YR; Lee, IS; Shin, BA; Sim, CJ; Sung, CK | 1 |
1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and lovastatin
Article | Year |
---|---|
Lyso-PAF analogues and lysophosphatidylcholines from the marine sponge Spirastrella abata as inhibitors of cholesterol biosynthesis.
Topics: Animals; Anticholesteremic Agents; Cell Line; Cells, Cultured; Cholesterol; Depression, Chemical; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation Mediators; Lanosterol; Liver; Lovastatin; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Platelet Activating Factor; Porifera | 1999 |